Caxton Associates (New York)’s Qiagen QGEN Stock Holding History

Caxton Associates (New York)’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-17,178	Closed	-$908K	–	610
2022 Q4	$908K	Sell	17,178 -9,264	-35%	-$457K	0.06%	130
2022 Q3	$1.16M	Buy	+26,442	New	+$1.31M	0.15%	83
2019 Q4	–	Sell	-10,549	Closed	-$369K	–	523
2019 Q3	$369K	Buy	+10,549	New	+$406K	0.07%	203

Other funds holding QGEN

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Caxton Associates (New York)'s QGEN Position: Q1 2023 in Review

Caxton Associates (New York) sold out of Qiagen (QGEN) in Q1 2023, closing a stake of 17,178 shares — an estimated $908K sold.

Caxton Associates (New York) first reported a position in QGEN in Q3 2019 and held it in 3 quarters. The position peaked at $1.16M in Q3 2022. 286 funds tracked by Wall St. Rank hold QGEN as of Q1 2023.

Caxton Associates (New York) reported no remaining Qiagen position as of Q1 2023 after selling out during the quarter.
Caxton Associates (New York) sold 17,178 Qiagen shares in Q1 2023, an estimated $908K.
Caxton Associates (New York) first reported a position in Qiagen in Q3 2019 and held it in 3 quarters.
Caxton Associates (New York)'s Qiagen position peaked at $1.16M in Q3 2022.
286 funds tracked by Wall St. Rank held Qiagen as of Q1 2023.

Based on Caxton Associates (New York)'s 13F filing for Q1 2023, filed 15 May 2023.